DOACs in the Anticoagulation of Mechanical Valves: A Systematic Review and Future Perspectives

DOACs in the Anticoagulation of Mechanical Valves: A Systematic Review and Future Perspectives

Valvular heart disease is a common disease often necessitating valve replacement. Mechanical heart valves (MHVs) are often used in younger patients because of their longer durability. Their main disadvantage is the need for lifelong anticoagulation. Warfarin is considered a standard treatment, but i...

Full description

Bibliographic Details
Main Authors: Tom Langenaeken, Arnaud Vanoppen, Fien Janssens, Loes Tanghe, Peter Verbrugghe, Filip Rega, Bart Meuris
Format: Article
Language:English
Published: MDPI AG 2023-07-01
Series:Journal of Clinical Medicine
Subjects:
DOAC
mechanical valve
anticoagulation
animal trials
human trials
mechanical valve thrombosis
Online Access:https://www.mdpi.com/2077-0383/12/15/4984

Similar Items

Similar Items